EuroPCR

In two trials, OCT-guided PCI demonstrated superiority in imaging endpoints and improved procedural success compared with angiography and fluoroscopy alone, speakers reported.

Transcatheter aortic valve replacement was associated with similar long-term mortality and stroke risk vs. surgery for severe aortic stenosis, but with greater risk for pacemaker implant with self-expanding TAVR valves, a speaker reported.

A new prosthetic aortic valve with a wider range of intermediate sizing was noninferior at 30 days vs. other contemporary transcatheter aortic valves, a speaker reported.

In younger patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement was associated with similar outcomes to surgical AVR, except in those with bicuspid valves, researchers reported.

In women with severe aortic stenosis and small aortic annuli who underwent transcatheter aortic valve replacement, a self-expanding valve was linked with better hemodynamic outcomes vs. a balloon-expandable valve at 1 year.

In patients with ACS who underwent PCI with a drug-coated balloon, an antiplatelet therapy de-escalation strategy was noninferior to 12-month dual antiplatelet therapy, researchers reported at EuroPCR.

A percutaneous approach to treatment of severe aortic stenosis and complex CAD was superior to surgical valve replacement and CABG, a speaker reported.

A drug-eluting coronary implant adaptable to vessel physiology with uncaging elements was linked to less target lesion failure and target vessel failure at 2 years compared with a drug-eluting stent, researchers reported.